Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000902680 | SCV001047111 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000383 | SCV001157151 | uncertain significance | not specified | 2019-04-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000902680 | SCV004137591 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | RLBP1: BP4 |
Prevention |
RCV003922999 | SCV004741053 | benign | RLBP1-related condition | 2020-03-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |